Dual device-drug therapy improves uncontrolled diabetes and obesity

(The Endocrine Society) Combining a temporary one-year intestinal bypass device with the drug liraglutide helps patients lose weight and improve their diabetes control better than using either the device or the drug alone, new research from the United Kingdom reports. The one-year results of the two-year study will be presented in a poster Saturday, April 2, at ENDO 2016, the annual meeting of the Endocrine Society in Boston.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news